You know the asset I’m talking about. It’s the Series C SaaS platform or the mid-market tech services firm that you acquired in 2021 at a 14x multiple. The thesis was simple: inject capital, professionalize sales, and exit in 36 months.
It is now Month 48. The company has missed its EBITDA target for three consecutive quarters. The "100-Day Plan" is collecting dust. And you are having the same circular conversation with the CEO about "pipeline velocity" and "Q4 catch-up" that you had last year.
You are not alone. We are currently living through a liquidity crisis disguised as a market correction. According to Bain & Company’s 2025 Global Private Equity Report, the industry is sitting on a record 31,000 unsold companies, valued at over $3 trillion. The median hold period has stretched to an all-time high of 5.9 years.
The era of "extend and pretend"—using cheap debt to float underperforming assets until the market turns—is over. With Distributed to Paid-In (DPI) ratios for recent vintages hovering around a dismal 0.3x, LPs are demanding liquidity, not excuses.
The danger for Operating Partners isn’t the asset itself; it’s the indecision. Every month you fund a "zombie" company’s burn rate, you are eroding the IRR of your entire fund. You are spending 80% of your time on an asset that represents 5% of your potential carry.
You need a ruthless, data-driven triage process. You don’t have six months for a McKinsey strategy refresh. You have 60 days to make a binary decision: Fix it, Sell it, or Shut it down.

Stop listening to the Founder’s stories about product roadmaps and start looking at the cold, hard unit economics. To determine the fate of a distressed asset, we deploy a 60-day diagnostic that ignores EBITDA (which can be manipulated) and focuses on value retention.
You double down ONLY if the core engine is sound but the chassis is heavy. This path is for companies with product-market fit but bloated operations.
You sell if the technology is valuable but the business model is broken. These companies often have high churn but proprietary IP that a strategic buyer (e.g., Salesforce, Oracle, or a larger portfolio co) needs.
The hardest decision, but often the most accretive to your time and sanity. These are the true zombies.
The math is rarely the problem; the politics are. Admitting a "Shut Down" or a fire sale feels like a failure of the Operating Partner's duty. But in 2026, the definition of success has shifted from "saving every company" to "saving the fund's DPI."
Your time is the scarcest resource in the portfolio. "Zombie" companies are time vampires. By applying this triage framework, you stop throwing good money (and time) after bad. You free up your operational bandwidth to focus on the 3-4 "Winners" in your portfolio that can actually return the fund.
As the PE Operator's Playbook dictates: Hope is not a strategy. Triage is.
